ENDO PHARMACEUTICALS HOLDINGS INC.
Table of Contents

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): March 20, 2003 (March 20,
2003)

ENDO PHARMACEUTICALS HOLDINGS INC.

(Exact name of registrant as specified in its charter)
             
DELAWARE     39040     13-4022871
           
(State or other jurisdiction of incorporation)     (Commission File Number)     (I.R.S. Employer Identification No.)
 
100 Painters Drive
Chadds Ford, Pennsylvania		           19317
           
(Address of principal executive offices)           (Zip Code)

(610) 558-9800

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

 

TABLE OF CONTENTS

Item 7. Financial Statements and Exhibits.
Item 9. Regulation FD Disclosure.
SIGNATURES
INDEX TO EXHIBITS
EX-99.1 PRESS RELEASE
EX-99.2 PRESS RELEASE

Table of Contents

Item 7. Financial Statements and Exhibits.

(a)   Financial Statements of Business Acquired.

     Not applicable.

(b)   Pro Forma Financial Information.

     Not applicable.

(c)   Exhibits.
     
Exhibit Number   Description
 
99.1   Press Release of Endo Pharmaceuticals Holdings Inc. dated March 20, 2003
99.2   Press Release of Endo Pharmaceuticals Holdings Inc. dated March 20, 2003

Item 9. Regulation FD Disclosure.

     On March 20, 2003, the Registrant issued two press releases in connection with the 22nd Annual Scientific Meeting of the American Pain Society in Chicago, Illinois, copies of which are attached as Exhibit 99.1 and Exhibit 99.2 to this Report and are incorporated herein by reference.

 

Table of Contents

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

         
        ENDO PHARMACEUTICALS HOLDINGS INC.
        (Registrant)
 
        By: /s/ CAROL A. AMMON
Name: Carol A. Ammon
Title: Chairman & Chief Executive Officer
 
Dated:  March 20, 2003      

 

Table of Contents

INDEX TO EXHIBITS

     
Exhibit No.   Description
 
99.1   Press Release of Endo Pharmaceuticals Holdings Inc. dated March 20, 2003
 
99.2   Press Release of Endo Pharmaceuticals Holdings Inc. dated March 20, 2003